Target
Chymotrypsinogen B2
Ligand
BDBM247411
Substrate
n/a
Meas. Tech.
ChEMBL_2155670 (CHEMBL5040330)
Ki
35±n/a nM
Citation
 Dilger, AKPabbisetty, KBCorte, JRDe Lucca, IFang, TYang, WPinto, DJPWang, YZhu, YMathur, ALi, JHou, XSmith, DSun, DZhang, HKrishnananthan, SWu, DRMyers, JESheriff, SRossi, KAChacko, SZheng, JJGalella, MAZiemba, TDierks, EABozarth, JMWu, YCrain, EWong, PCLuettgen, JMWexler, RREwing, WR Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy. J Med Chem 65:1770-1785 (2022) [PubMed]  Article 
Target
Name:
Chymotrypsinogen B2
Synonyms:
3.4.21.1 | CTRB2 | CTRB2_HUMAN | Chymotrypsin B2 chain A | Chymotrypsin B2 chain B | Chymotrypsin B2 chain C | Chymotrypsinogen B2
Type:
PROTEIN
Mol. Mass.:
27926.36
Organism:
Homo sapiens
Description:
ChEMBL_119704
Residue:
263
Sequence:
MAFLWLLSCWALLGTTFGCGVPAIHPVLSGLSRIVNGEDAVPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVRTSDVVVAGEFDQGSDEENIQVLKIAKVFKNPKFSILTVNNDITLLKLATPARFSQTVSAVCLPSADDDFPAGTLCATTGWGKTKYNANKTPDKLQQAALPLLSNAECKKSWGRRITDVMICAGASGVSSCMGDSGGPLVCQKDGAWTLVGIVSWGSRTCSTTTPAVYARVAKLIPWVQKILAAN
  
Inhibitor
Name:
BDBM247411
Synonyms:
US10336754, Example 353 | US11053247, Example 353 | US9453018, 353
Type:
Small organic molecule
Emp. Form.:
C28H23Cl2F2N9O2
Mol. Mass.:
626.444
SMILES:
C[C@@H]1CCC[C@@H](c2cc(ccn2)-c2c(NC1=O)cnn2C(F)F)n1cnc(cc1=O)-c1cc(Cl)ccc1-n1cc(Cl)nn1 |r|
Structure:
Search PDB for entries with ligand similarity: